PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28321644-4	2017	The aim of this study is to examine the effect of vinpocetine on pathological cardiac remodeling induced by chronic stimulation with angiotensin II (Ang II).	vinpocetine	50-61	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	133-147	
28321644-4	2017	The aim of this study is to examine the effect of vinpocetine on pathological cardiac remodeling induced by chronic stimulation with angiotensin II (Ang II).	vinpocetine	50-61	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	149-155	
28321644-5	2017	METHODS: Mice received Ang II infusion via osmotic pumps in the presence of vehicle or vinpocetine.	vinpocetine	87-98	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	23-29	
28321644-8	2017	RESULTS: We showed that chronic Ang II infusion caused cardiac hypertrophy and fibrosis, which were all significantly attenuated by systemic administration of vinpocetine.	vinpocetine	159-170	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	32-38	
28321644-9	2017	In isolated adult mouse cardiomyocytes, vinpocetine suppressed Ang II-stimulated myocyte hypertrophic growth.	vinpocetine	40-51	angiotensinogen (serpin peptidase inhibitor, clade A, member 8)	Mus musculus	63-69